Phoenix Life Sciences International Limited
PLSI · OTC
2/28/2019 | 11/30/2018 | 8/31/2018 | 5/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,227 | $210 | $0 | $0 |
| SG&A Expenses | $126 | $210 | $0 | $0 |
| Sales & Mktg Exp. | $124 | $0 | $0 | $0 |
| Other Operating Expenses | $1,651 | -$1,519 | -$25 | $0 |
| Operating Expenses | $1,450 | $1,612 | -$25 | $0 |
| Operating Income | -$1,450 | -$1,612 | -$25 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,656 | -$1,276 | -$228 | -$140 |
| Pre-Tax Income | $205 | -$2,888 | -$294 | -$140 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $205 | -$2,888 | -$294 | -$140 |
| % Margin | – | – | – | – |
| EPS | 5.87 | -82.56 | -6.19 | -4.01 |
| % Growth | 107.1% | -1,233.8% | -54.4% | – |
| EPS Diluted | 5.87 | -82.56 | -8.4 | -4.01 |
| Weighted Avg Shares Out | 35 | 35 | 35 | 35 |
| Weighted Avg Shares Out Dil | 35 | 35 | 35 | 35 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $25 | $24 |
| Depreciation & Amortization | $46 | $45 | $41 | $1,651 |
| EBITDA | $201 | -$3,131 | -$25 | -$131 |
| % Margin | – | – | – | – |